FIP Cure Pioneer

At NeoFipronis® (Pronidesivir), we are committed to transforming feline care. As the pioneer of the world’s first officially approved oral treatment for FIP, our mission is clear: make effective, accessible, and trusted medicine available to every cat in need.

It’s about healing with trust. It’s about giving every cat a second chance.

The NeoFipronis® (Pronidesivir) Story

NeoFipronis® (Pronidesivir) was born from a deep commitment to feline health and clinical excellence. As the world’s first officially approved oral treatment for feline infectious peritonitis (FIP), it represents a milestone in veterinary medicine—developed in collaboration with leading veterinary researchers and clinicians.

Our product is driven by science and defined by quality. Manufactured under strict veterinary GMP standards, every batch of NeoFipronis® (Pronidesivir) undergoes rigorous testing to ensure safety, consistency, and therapeutic reliability.

NeoFipronis® (Pronidesivir) is more than a treatment—it’s a symbol of hope. Trusted by veterinarians and cat owners worldwide, we are dedicated to providing a proven, accessible, and non-invasive solution to help every FIP-affected cat reclaim its life.

Whether you’re a veterinarian, a devoted cat parent, or a global distributor, you can rely on us for science-backed, vet-recommended therapy — with compassion at the core.

Why Choose NeoFipronis®

NeoFipronis® (Pronidesivir) offers a proven, vet-recommended solution for treating all forms of feline infectious peritonitis (FIP). With high bioavailability, excellent safety, and an easy-to-administer oral formulation, it helps cats recover faster, improves quality of life, and lowers the risk of relapse—making it the trusted choice for cat owners worldwide.

Officially Approved

Approved for marketing with manufacturing to rigorous quality standards.

Proven & Practical

Clinically demonstrated efficacy with once‑daily oral tablets for better adherence.

Comprehensive Support

Treatment guidance, dose calculators, and verification tools to ensure safe and effective use.

Trusted by Vets

Used under veterinary supervision with ongoing monitoring best practices.

NEW Breakthrough in Feline Health!

We’re proud to introduce NeoFipronis® (Pronidesivir) — the world’s first officially approved oral treatment for FIP in cats. In partnership with leading veterinary researchers, we’re bringing life-saving innovation to felines worldwide.

Who We Serve

Mother and child illustration

Pet Owners

We provide trusted, science-backed FIP treatment to give your cat the chance it deserves—because every purr matters.

School-age girl

Veterinary Clinics

Partnering with licensed clinics to deliver compliant, effective care for cats diagnosed with FIP.

Elderly couple

Global Distributors

We welcome global partners to join us in making Pronidesivir accessible to cats in need around the world.

NeoFipronis® (Pronidesivir)
— The World’s First Officially Approved Oral Treatment for FIP in Cats

NeoFipronis® (Pronidesivir) is the first officially approved oral medication for the treatment of feline infectious peritonitis (FIP), marking a major breakthrough in feline medicine. Designed specifically for FIP-infected cats, it offers a scientific, reliable, and non-invasive treatment solution. We are committed to supporting veterinarians, cat owners, and global distributors in providing safe and effective care—giving every cat a true chance at recovery.

The Treatment You Trust. The Quality Your Cat Deserves.

With NeoFipronis® (Pronidesivir), you’re choosing a scientifically proven FIP treatment backed by veterinary expertise and strict quality control. Every tablet reflects our commitment to safety, consistency, and care.

In a field where accuracy can mean life or death,Pronidesivir raises the standard. From formulation to packaging, we follow rigorous protocols to ensure every dose delivers what your cat needs — no compromises, no shortcuts.

Why Choose NeoFipronis:

  • First officially approved oral treatment for FIP
  • Manufactured under strict veterinary standards
  • Trusted by vets, backed by science
  • Accurate dosage, easy and safe to administer
  • Multiple quality checks for consistent efficacy
  • Globally compliant and internationally available

NeoFipronis — your trusted solution for FIP treatment.

INDICATION AND IMPORTANT SAFETY INFORMATION

WHAT IS NEOFIPRONIS® (Pronidesivir)?

NeoFipronis® (Pronidesivir) is a non-prescription veterinary medicine used for the treatment of feline infectious peritonitis (FIP) in cats. It is indicated for all known forms of FIP, including effusive (wet), non-effusive (dry), neurological, and ocular types.

NeoFipronis® (Pronidesivir) is not approved for use in humans and should only be administered to cats. Use under the guidance of a licensed veterinarian is strongly recommended.

Do not exceed the recommended daily dosage. Overdosing may increase the risk of adverse effects, including liver or kidney strain.

IMPORTANT SAFETY INFORMATION

Before giving NeoFipronis® (Pronidesivir) to your cat, tell your veterinarian if your cat:

  • Is under 4 weeks of age
  • Is pregnant or suspected to be pregnant
  • Has known liver or kidney disease
  • Is receiving other medications, supplements, or undergoing concurrent treatment

Using NeoFipronis® (Pronidesivir) with other medications may alter its effectiveness or increase the risk of interactions. Always inform your veterinarian of any other treatments your cat is receiving.

The standard dose is 15mg/kg orally once daily on an empty stomach. Higher doses (up to 30mg/kg) may be needed for cats with neurological or ocular FIP. Do not change the dosage without veterinary advice.

What are the possible side effects of NeoFipronis® (Pronidesivir) ?

The most commonly observed side effects include vomiting, loss of appetite, lethargy, and mild gastrointestinal discomfort. These effects are generally manageable and reversible. Serious adverse effects are rare when used as directed.

Regular monitoring of your cat’s bloodwork—including liver and kidney function—is recommended during treatment. Discontinue use and contact your veterinarian immediately if serious reactions occur.

Talk to your veterinarian for medical advice about side effects or concerns regarding treatment.

NeoFipronis® (Pronidesivir) is a non-prescription veterinary medicine, and its use under veterinary supervision is strongly recommended.

Keep out of reach of children and animals. Not for human use.

For full prescribing information and product details, please visit:www.pronidesivir.com.